Sign up
Log in
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Medicus Pharma (NASDAQ:MDCX) stock moved upwards by 12.0% to $1.68 during Tuesday's pre-market session. The company's market cap stands at $37.0 million.
  • Rafael Holdings (NYSE:RFL) shares increased by 10.34% to $1.6. The market value of their outstanding shares is at $75.0 million.
  • Adial Pharmaceuticals (NASDAQ:ADIL) stock rose 9.71% to $2.71. The market value of their outstanding shares is at $2.7 million.
  • Spectral AI (NASDAQ:MDAI) shares moved upwards by 8.51% to $1.53. The market value of their outstanding shares is at $43.2 million.
  • Select Medical Hldgs (NYSE:SEM) stock moved upwards by 7.13% to $16.07. The company's market cap stands at $1.8 billion.
  • Impact BioMedical (AMEX:IBO) shares increased by 6.01% to $0.42. The company's market cap stands at $4.8 million.

Losers

  • Iterum Therapeutics (NASDAQ:ITRM) shares declined by 37.9% to $0.18 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.9 million.
  • MAIA Biotechnology (AMEX:MAIA) stock fell 25.13% to $1.55. The market value of their outstanding shares is at $76.6 million.
  • Surgery Partners (NASDAQ:SGRY) shares decreased by 23.87% to $12.09. The market value of their outstanding shares is at $2.0 billion. As per the news, the Q4 earnings report came out yesterday.
  • Harrow (NASDAQ:HROW) shares fell 14.11% to $46.03. The company's market cap stands at $1.9 billion. As per the press release, Q4 earnings came out yesterday.
  • Ensysce Biosciences (NASDAQ:ENSC) shares declined by 13.84% to $0.52. The market value of their outstanding shares is at $2.1 million.
  • Indaptus Therapeutics (NASDAQ:INDP) shares decreased by 13.81% to $1.81. The market value of their outstanding shares is at $4.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.